Advanced
Novel and Efficient Synthesis of Tetrazolo[1,5-b]-1,2,5-oxadiazepines as Antibacterial Activities from Ethyl 1-aminotetrazole-5-carboxylate
Novel and Efficient Synthesis of Tetrazolo[1,5-b]-1,2,5-oxadiazepines as Antibacterial Activities from Ethyl 1-aminotetrazole-5-carboxylate
Journal of the Korean Chemical Society. 2011. Dec, 55(6): 974-977
Copyright © 2011, The Korean Chemical Society
  • Received : July 02, 2011
  • Accepted : September 06, 2011
  • Published : December 20, 2011
Download
PDF
e-PUB
PubReader
PPT
Export by style
Article
Author
Metrics
Cited by
TagCloud
About the Authors
Susan M. El-Badry
Mamdouh A. M. Taha
Chemistry Department, Faculty of Science, Faiyoum University, Faiyoum 63514, Egypt
mamdouhamtaha@yahoo.com

Abstract
Ethyl 1-aminotetrazole-5-carboxylate (1) has been utilized to construct a variety of novel tetrazolo [1,5- b ]-1,2,5-oxadiazepine derivatives which repesent a relatively little explored group with interesting antibacterial activities. The synthesized compounds were elucidated using IR, 1 H NMR and mass spectroscopic methods, besides elemental analyses.
Keywords
INTRODUCTION
Tetrazoles and their derivatives have been described as useful building blocks for the assembly of different heteroyclic rings 1 - 7 because of their wide range of therapeutic and biological properties. 8 , 9 They have emerged as antibacterial, antiproliferation, anticancer, and anticonvulsant activities. 1 - 5 , 10 - 12 Numerous studies have been reported 13 - 24 on the synthesis of a variety of oxadiazepine derivatives covering a wide range of bioorganic, natural products, and medicinal chemistry. They are an important class of heterocyclic compounds that have pharmaceutical and biological activities 13 , 21 - 24 including antiherbicide, antimicrobial, antifungal, and anticancer. All these facts encouraged us to synthesize some new tetrazolo[1,5- b ]-1,2,5-oxadiazepines in anticipation of expected interesting antibacterial activities.
RESULTS AND DISCUSSION
- Chemsitry
The diazotization of ethyl 1-aminotetrazole-5-carboxylate 1 (1) in the presence of water resulted in the formation of ethyl 1-hydroxytetrazole-5-carboxylate (2) , which is used as a starting compound for bromoketone systems. Thus, condensation of 2 with bromoacetone and/or phenacylbromide in absolute ethanol in the presence of anhydrous potassium carbonate to provide acetonyloxy 3a and 2-oxyacetophenone 3b , respectively. The IR spectra of 3(a,b) showed ester carbonyl (COOEt) bands in 1740, 1760 cm -1 and carbonyl (COCH 3 (ph)) bands in 1712, 1720 cm -1 region. 1 H NMR spectra of 3a and 3b revealed four signals in the d 4.19, 4.23; 2.45, 2.40, 1.30, 1.33 and 2.35, 8.35-7.20 ppm which were attributed to be CH 2 CH 3 , CH 2 COCH 3 (Ph) CH 2 CH 3 and CH 2 CO CH 3 (Ph), respectively. The El-MS spectra of 3a and 3b showed the molecular ion peaks at m/z : 214 (M + ) and 277 (M + +1) corresponding to C 7 H 10 N 4 O 4 and C 12 H 12 N 4 O 4 , respectively.
7-Methyl(phenyl)-8-aryltetrazolo[1,5- b ]-1,2,5-oxadiazepin-9-ones 4(a-l) ( 1 ) were obtained by condensation of 3(a,b) with various 4-substituted anilines in the presence of acetic anhydride/acetic acid ( 1 ). The IR spectra of 4(a-l) showed bands at 1650-1985 cm -1 ( 2 ) which were attributed to the amide (CON) stretching frequency and disappearance any COOEt or COCH 3 (ph) absorption bands present in the spectra of the parent compounds 3(a,b) . In the 1 H NMR spectra of 4(a-l) not only revealed the absence of both the methylene proton (CH 2 ) and the ethyl protons but also the presence of the methine proton (CH) of oxadiazepine ring at d 5.44-5.39 besides aromatic protons at 8.22-6.99 ppm ( 2 ). Moreover, the mass spectra of 4(a-l) gave their correct parent ion peaks corresponding to their molecular formulas ( 2 ).
PPT Slide
Lager Image
Physical and analytical data of4(a-l)
PPT Slide
Lager Image
Physical and analytical data of 4(a-l)
Spectral data of4(a-l)
PPT Slide
Lager Image
Spectral data of 4(a-l)
- Biological activities
Antibacterial activities of the aryl tetrazolo[1,5- b ]-1,2,5-oxadiazepin-9-ones 4 listed in 3 were assessed against Gram-positive ( Staphylococus aureus and Bacillus subtilis ) and Gram-negative ( Escherichia coli and Klebsiella peneumoniae ) bacteria. Ciprofloxacin and Norfloxacin were used as antibacterial standarsds. The antibacterial activity against Gram-postive organisms had the most activity. However, all the compounds were nearly inactive against Gram-negative bacteria.
In vitro antibacterial activity of4and standards (MIC in μg/ml)
PPT Slide
Lager Image
In vitro antibacterial activity of 4 and standards (MIC in μg/ml)
CONCLUSION
A successful preparation and characterization of new compounds substituted aryl tetrazolo[1,5- b ]1,2,5-oxadiazepin-9-ones 4(a-l) from condensation of acetonyloxy 3a and oxyacetophenone 3b tetrazoles with various 4-substituted anilines in the presence of acetic anhydride/acetic acid. The antibacterival activities of the prepared compounds were comparable to Ciprofloxacim and Norfloxacin and study showed that, against Gram-positive bacteria is in contrast to the good antibacterial activity of Ciprofloxacim aginst both Gram-positive and Gram-negative bacteria.
EXPERIMENTAL
- General
Melting points were determined by using a Buchi-530 melting point apparatus and are uncorrected. Spectroscopic data were recorded on the following instruments. Infrared (IR) spectra (KBr, ν cm -1 ) Perkin Elmer 1240 spectrophotomer, nuclear magnetic resonance ( 1 H NMR) spectra (chemical shift, e ppm) Varian Mercury (300 MHz) spectrometer using TMS as internal standard and electron impact Mass spectra (El-MS) GC-MS (QP/000EX) Shimadzu spectrometer (70 ev). Elemental analyses were performed by the Microanalysis Centre, Faculty of Science, Cairo University. The purity of the compounds was confirmed by Thin Layer Chromatography(TLC) on silica gel HF 254 (Merck).
- Ethyl 1-hydroxytetrazole-5-carboxylate (2)
To a cooled solution (-5 ℃) of 1 (1 g, 6 mmol) in concentrated hydrochloric acid (2N, 4 ml) was added portionwise sodium nitrite (0.4 g, 6 mmol). After stirring at room temperature for an hour, water (10 ml) was added to the mixture which was then heated under reflux for half hour. It was cooled at ambient temperature and neutralized with ammonium hydroxide solution. The precipitate was collected by filtration washed with water and purified by crystallization from aqueous ethanol to obtain 2 (0.7 g, 69% yield), m.p. 288-290 ℃; IR (KBr, ν cm -1 ): 33340 (OH), 1750 (COOEt); 1 H NMR ( DMSO - d 6 , d/ppm): 12.30 (s, 1H, OH, D 2 O exchangeable), 4,23 (q, 2H, CH 2 CH 3 ); 1.25 (t, 3H, CH 2 CH 3 ); El-MS: m/z (%): 159 (M + +1, 38); 158 (M + , 79).
Anal. Calcd. for C 4 H 6 N 4 O 3 (158): C, 30.38; H, 3.80; N, 35.44%; Found: C, 30.67; H,4.12; N, 35.90%.
- Ethyl 1-acetonyloxytetrazole-5-carboxylate (3a)
To a solution of 2 (1 g, 6 mmol) in absolute ethanol (20 ml) was added bromoacetone (0.9 g, 6 mmol) in anhydrous potassium carbonate (2 g). The reaction mixture was refluxed for 3 hours and then left to cool 24 hours. The separated solid product was filtered and crystallized from aqueous ethanol to give 3a (0.8 g, 57 % yield), m.p. 260-262 ℃; IR (KBr, ν cm -1 ): 1740 (COOEt), 1712 (COCH 3 ); 1 H NMR ( DMSO - d 6 , d/ppm): 4.19 (q, 2H, CH 2 CH 3 ), 2.45 (s, 2H, CH 2 COCH 3 ), 2.35 (s, 3H, CH 2 CO CH 3 ), 1.30 (t, 3H, CH 2 CH 3 ); El-MS: m/z (%): 214 (M + , 80).
Anal. Calcd. for C 7 H 10 N 4 O 4 (214): C, 39.25; H, 4.67; N, 29.91%; Found: C, 39.70, H, 5.11; N, 30.23%.
- Ethyl 1-(2-oxyacetophenone) tetrazole-5-carbolylate (3b)
To a solution of 2 (1 g, 6 mmol) in absolute ethanol (20 ml) was added phenacyl bromide (1.3 g, 6 mmol) and anhydrous potassium carbonate (2 g). The reaction mixture was heated under reflux for 3 hours and then left to cool overnight. The separated solid product was filtered and crystallized from aqueous ethanol to give 3b (1.2 g, 67% yield), m.p. 238-240 ℃; IR (KBr, ν cm -1 ): 1760 (COOEt), 1720 (COPh); 1 H NMR ( DMSO - d 6 , d/ppm: 8.35-7.20 (m, 5H, ArH), 4.23 (q, 2H, CH 2 CH 3 ), 2.40 (s, 2H, CH 2 COPh), 1.33 (t, 3H, CH 2 CH 3 ); El-MS: m/z (%): 277 (M + +1, 65).
Anal. Calcd. for C 17 H 12 N 4 O 4 (276): C, 52.17; H, 4.35; N, 20.29%; Found: C, 51.96; H, 4.88; N, 20.72%.
- General procedure for the preparation of 7-Methyl (phenyl)-8-aryltetrazolo[1,5-b]-1,2,5-oxadiazepin-9-ones 4(a-l)
A mixture of 3a or 3b (5 mmol) the appropriate 4-substituted aniline (5 mmol) and acetic anhydride (10 ml) in glacial acetic acid (15 ml) was refluxed for two hours. The solvent was evaporated under reduced presure and the residue was crystallized from ethanol. The physico-chemical and spectral data of 4(a-l) are given in 1 and 2 , respectively.
- Antibacterial assay
The in vitro antibacterial activity of the synthesized compounds against Gram-positive organisms ( S. aureas and B. subtilis ) and Gram-negative ( E. coli and K. peneumoniae ) organisms was done by conventional agar dilution methods 25 and compared with those of Ciprofloxacim and Norfloxacin. Twofold serial dilution of the compounds and reference drugs were used in Müller-Hinton Broth (oxoid) agar. Drugs were dissolved in dimethylsulfoxide ( DMSO ; 1 ml) and the solution was diluted with water (9 ml). Further progressive double dilution with melted Müller-Hinton Broth (oxoid) agar was performed to give the required concentrations. The Minimum Inhibitor Concentration (MIC) was the lowest concentration of the test compound, which yielded in no visible growth on the plate. To ensure that the solvent had no effect on bacterial growth, a control test was performed with test medium supplemented with DMSO at the same dilutions as prepared in the experiment.
References
Taha M. A. M. , El-Badry S. M. 2010 J. Korean Chem. Soc. 54 414 -    DOI : 10.5012/jkcs.2010.54.4.414
Taha M. A. M. , El-Badry S. M. 2008 Monatsh. Chem. 139 1261 -    DOI : 10.1007/s00706-008-0902-8
Taha M. A. M. 2008 Phosphorus, Sulphur, Silicon Relat. Elem. 183 2525 -    DOI : 10.1080/10426500801967773
Taha M. A. M. 2007 Monatsh. Chem. 138 505 -    DOI : 10.1007/s00706-007-0599-0
Taha M. A. M. , El-Badry S. M. 2007 Phosphorus, Sulfur, Silicon Relat. Elem. 182 1011 -    DOI : 10.1080/10426500601090768
Taha M. A. M. , El-Badry S. M. 2006 J. Chinese Chem. Soc. 53 1181 -
Taha M. A. M. 2005 Ibid 52 137 -
Moderhack D. 1998 J. Prakt. Chem. 340 687 -    DOI : 10.1002/prac.19983400802
Kolodobskii G. I. , Ostrovskii V. A. , Popavskii V. S. 1981 Chem. Heterocycl. Compd. 17 965 -    DOI : 10.1007/BF00503523
Karnik A. V. , Malviya N. J. , Kulkarni A. M. , Jadhav B. L. 2006 Eur. J. Med. Chem. 41 891 -    DOI : 10.1016/j.ejmech.2006.01.018
Jantova S. , Ruzekova L. , Stantovsky S. , Spirkova K. 1997 Neoplasma 44 240 -
Rubat C. , Coadert P. , Couqvelet J. M. , Tronche P. , Bastide J. , Bastide P. 1990 Farmaco 45 331 -
Muehlebach M. , Boeger M. , Cederbaum F. , Cornes D. , Friedmann A. A. , Glock J. , Niderman T. , Stoller A. , Wagner T. 2009 Bioorg. Med. Chem. 17 4241 -    DOI : 10.1016/j.bmc.2008.12.062
Kumar R. R. , Perumal S. , Balasubramanian M. 2008 Comprehensive Heterocycl. Chem. (III) 13 433 -
Yranzo G. I. , Moyano E. L. 2008 Ibid 13 399 -
Kiselyov A. , Khvat A. 2008 Ibid 13 387 -
Denisko O. V. 2008 Ibid 13 489 -
Souldozi A. , Ramazani A. , Bouslimani N. , Welter R. 2007 Tetrahedron Lett. 48 2617 -    DOI : 10.1016/j.tetlet.2007.02.010
Ochoa M. E. , Rojas-Lima S. , Höpfl H. , Rodriguez P. , Castillo D. , Farfan N. , Santillan R. 2001 Tetrahedron 57 55 -    DOI : 10.1016/S0040-4020(00)00984-4
Autio K. , Pyysalo H. 1983 J. Agric. Food Chem. 31 568 -    DOI : 10.1021/jf00117a025
ÓConnell A. J. , Peek C. J. , Sammes P. G. 1983 J. Chem. Soc., Chem. Commun. 399 -    DOI : 10.1039/c39830000399
Ishiwata S. , Shiokawa Y. 1970 Chem. Pharm. Bull. 18 1245 -    DOI : 10.1248/cpb.18.1245
Druey J. , Daeniker H. U. 1962 Swiss Pat. 358 430 -
Daeniker H. U. , Druey J. 1957 Helv. Chim. Acta 40 918 -    DOI : 10.1002/hlca.19570400406
Baron E. J. , Finegold S. M. 1990 Bailey and Scott’s, Diagnostic Microbiology 8th ed. Mosby St. Louis, MO 184 -